Corient Private Wealth LLC Decreases Stake in Chemed Co. (NYSE:CHE)

Corient Private Wealth LLC cut its stake in Chemed Co. (NYSE:CHE - Free Report) by 15.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,288 shares of the company's stock after selling 426 shares during the period. Corient Private Wealth LLC's holdings in Chemed were worth $1,212,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the stock. Raymond James Financial Inc. purchased a new position in shares of Chemed in the fourth quarter worth about $42,023,000. FMR LLC raised its position in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after buying an additional 45,917 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock valued at $39,554,000 after acquiring an additional 39,791 shares during the period. Aureus Asset Management LLC boosted its holdings in shares of Chemed by 3,147.2% in the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock valued at $17,993,000 after acquiring an additional 29,017 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in shares of Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after acquiring an additional 22,105 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.

Remove Ads

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Brian C. Judkins purchased 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The shares were bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. The trade was a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is owned by company insiders.

Chemed Stock Down 1.0 %

Shares of NYSE CHE traded down $6.42 during midday trading on Friday, reaching $605.94. 162,388 shares of the stock were exchanged, compared to its average volume of 93,565. The firm has a market cap of $8.87 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 2.15 and a beta of 0.43. The firm has a 50-day simple moving average of $574.16 and a two-hundred day simple moving average of $566.66. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $642.68.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed's dividend payout ratio is presently 10.05%.

Analysts Set New Price Targets

CHE has been the subject of a number of research reports. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their price objective on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a report on Friday, March 14th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.